STATCenter·
STAT+: Alnylam says Huntington’s drug shows promise in early study
It’s yet to be seen whether Alnylam’s drug will actually slow progression of Huntington’s, but the field is lively.
Read at STAT →
Health · 1 sources covering this
STAT+: Alnylam says Huntington’s drug shows promise in early study
It’s yet to be seen whether Alnylam’s drug will actually slow progression of Huntington’s, but the field is lively.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/0c4be4ac0965fb5e4ef5a8762876f3243a327751" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Alnylam says Huntington’s drug shows promise in early study"></iframe>
